Biomedicines | Free Full-Text | Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
Klinika Hematologii - Instytut Hematologii i Transfuzjologii - Portal Pacjenta
Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
Frontiers | A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
Bayesian combination of mechanistic modeling and machine learning (BaM3): improving personalized tumor growth predictions
TVmed - wiedza medyczna dla profesjonalistów
Dzisiaj rusza ogólnopolska kampania edukacyjna „Choroby Krwi” | Hematoonkologia.pl
Rebecca Silbermann M.D., M.M.S. | OHSU People | OHSU
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma | Journal of Medicinal Chemistry
Immunochemotherapy for Richter syndrome: current insights: ImmunoTargets and Therapy: Vol 8
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model | SpringerLink
Opieka nad pacjentami hematoonkologicznymi zakażonymi SARS-CoV-2 uczy pokory - Puls Medycyny - pulsmedycyny.pl
PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium - ScienceDirect
Frontiers | Notch-Signaling Deregulation Induces Myeloid-Derived Suppressor Cells in T-Cell Acute Lymphoblastic Leukemia
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results f
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
Jak leczyć pacjenta z nowo rozpoznaną amyloidozą łańcuchów lekkich pośredniego ryzyka? Rola doksycykliny w terapii amylo
